Member directory

Quay Pharma

Quay Pharmaceuticals is experienced in providing a comprehensive out-sourcing service for formulation and analytical development with subsequent clinical trials manufacturing for pharmaceutical and biotechnology companies world-wide. Working as a dedicated, pro-active part of your team we apply strong project management and technical expertise to take products quickly and cost effectively from late stage pre-clinical through to the end of phase III clinical trials and commercial manufacturing. Quay Pharma has vast expertise in dosage form design and development and with Professor Mike Rubinstein (CEO), Prof L Gifford (CSO) and Professor John Collett (CSO), Quay Pharma has built a reputation for specialising in the formulation of API’s that exhibit poor solubility and bio-availability and those which require modified or controlled release. We are now a MHRA and FDA inspected and approved company.

Website

www.quaypharma.com

Email

enquiries@quaypharma.com

Telephone

+44 (0)1244 837000

Address

Quay House
28 Parkway
Deeside Industrial Park

Deeside

CH5 2NS

Quay Pharma
Quay House
28 Parkway
Deeside Industrial Park
Deeside
CH5 2NS

Quay Pharma news articles

30 September 2019

Quay Pharma partnering this years Microbiome Movement – Drug Development & Nutrition Asia Summit


Read more

2 November 2016

Quay Pharma to supply promising cancer drug for trial


Read more

9 May 2016

Quay Pharma is awarded Eurostars funding for oncology project


Read more